Kerttu Murumets

Title: Innovations by Kerttu Murumets in Cell Line Development

Introduction

Kerttu Murumets, an accomplished inventor based in Össu, Estonia, has made significant contributions to the field of biotechnological innovation. With a focus on developing stable mammalian cell lines, she holds a notable patent that advances methodologies in cellular engineering. Her work is essential for numerous applications in biotechnology and pharmaceutical research.

Latest Patents

Kerttu Murumets is credited with a patent titled "Platform for developing stable mammalian cell lines." This patent outlines methods and constructs known as landing pads, which facilitate the generation of parental cell lines optimized for targeted integration. By introducing binding sites of the BPV1 E2 protein to landing pad vectors, Murumets' approach ensures precise localization of the expression of the BPV1 E2 protein to transcriptionally active regions of the genome. The cells selected for their high expression levels of reporter genes pave the way for developing cell lines that express other recombinant proteins through recombination mediated cassette exchange (RMCE). Her landing pad constructs include site-specific recombination target sites, allowing for gene-of-interest constructs to be effectively replaced, thus simplifying cell line development compared to traditional methods.

Career Highlights

Kerttu has established a career that intersects innovation and practical application in cell line development. As an inventor at Icosagen Cell Factory OÜ, she utilizes her expertise to contribute to the advancement of biotechnology practices. Her commitment to improving methodologies for cell line development underscores her dedication to the field.

Collaborations

Throughout her career, Kerttu has collaborated with esteemed colleagues such as Mart Ustav, Jr. and Kadri Õunap. These collaborations have enhanced her research initiatives and fostered an environment of innovation within her workplace, further strengthening the impact of their collective efforts in the biotechnology sector.

Conclusion

Kerttu Murumets exemplifies the spirit of innovation in the realm of biotechnology through her pioneering patent in stable mammalian cell line development. Her work at Icosagen Cell Factory OÜ and collaborations with other skilled professionals highlight her importance in advancing research and applications in this critical field. Through her inventions, Kerttu continues to influence the future of cellular engineering and biotechnology.